z-logo
open-access-imgOpen Access
Evaluation and quantification of the inhibition of biofilm and planktonic forms of Klebsiella pneumoniae by the polyphenolic extract of Pulicaria crispa
Author(s) -
Afif Chaouche Thinina,
Karim Houali,
Malek Maliya Alia,
Abdallah Karim
Publication year - 2020
Publication title -
journal of advanced pharmaceutical technology and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.325
H-Index - 33
eISSN - 2231-4040
pISSN - 0976-2094
DOI - 10.4103/japtr.japtr_165_19
Subject(s) - biofilm , polyphenol , gallic acid , klebsiella pneumoniae , chemistry , minimum inhibitory concentration , antimicrobial , microbiology and biotechnology , quercetin , antibiotics , traditional medicine , food science , biochemistry , biology , bacteria , escherichia coli , antioxidant , medicine , genetics , gene
Analyses of polyphenolic plant extracts have shown significant results when used to control different pathogens. Many of these pathogens are responsible for different infections causing significant public health problems. This work aims basically to determine the efficiency of polyphenolic extract of Pulicaria crispa to prevent biofilm formation by Klebsiella pneumoniae . Strains were identified by their biochemical characters and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. P. crispa is a Saharan plant used to extract polyphenols to assess their inhibitory action against K. pneumoniae development and biofilm forming. High-performance liquid chromatography revealed quercetin as the most important component of the polyphenolic extract. All strains are biofilm forming and are resistant to many antibiotics. The Minimal inhibitory concentrations of biofilm (MICBs) of the extract range from 0.21 mg gallic acid equivalent (GAE) to 3.40 mg GAE. The minimal inhibitory concentrations vary from 0.1 mg GAE to 0.425 mg GAE. Although many plant extracts have already shown their antimicrobial and antibiofilm activities, their application in clinical cases requires a long-term endeavor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here